Nasdaq

Recursion Announces the Release of OpenPhenom-S/16 in Google Cloud’s Model Garden

OpenPhenom is a non-commercial, publicly available foundation model built on microscopy data that has set the new "gold standard" outperforming CellProfiler SALT LAKE CITY, Nov. 12, 2024 (GLOBE ...
VentureBeat

Samsung AI researcher's new, open reasoning model TRM outperforms models 10,000X larger — on specific problems

The trend of AI researchers developing new, small open source generative models that outperform far larger, proprietary peers continued this week with yet another staggering advancement. The goal is ...

VectorCertain Unveils Micro-Recursive Model Architecture That Extends AI Safety Coverage Into Statistical Tails Where Catastrophic Events Occur

-- VectorCertain introduces MRM-CFS, ultra-compact AI models for improved safety in edge cases. -- Existing AI systems fail on rare events; MRM-CFS offers precise detection and fusion solutions. -- ...
Nasdaq

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

SALT LAKE CITY, TORONTO and MONTRÉAL, July 12, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today ...
Benzinga.com

Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT

Shares of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict ...
Seeking Alpha

MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy

Boltz-2 is the first biomolecular co-folding model to combine structure and binding affinity prediction, approaching the accuracy of physics-based free energy perturbation (FEP) calculations but at ...
Seeking Alpha

Recursion Announces the Release of OpenPhenom-S/16 in Google Cloud’s Model Garden

SALT LAKE CITY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today the release of ...